Recombinant ROR1 (Zilovertamab Biosimilar) anticorps
Aperçu rapide pour Recombinant ROR1 (Zilovertamab Biosimilar) anticorps (ABIN7581651)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Expression System
- CHO Cells
-
Fonction
- Anti-ROR1 Reference Antibody (zilovertamab)
-
Séquence
- QVQLQESGPG LVKPSQTLSL TCTVSGYAFT AYNIHWVRQA PGQGLEWMGS FDPYDGGSSY NQKFKDRLTI SKDTSKNQVV LTMTNMDPVD TATYYCARGW YYFDYWGHGT LVTVSSASTK GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSRDELTKN QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPGK,DIVMTQTPLS LPVTPGEPAS ISCRASKSIS KYLAWYQQKP GQAPRLLIYS GSTLQSGIPP RFSGSGYGTD FTLTINNIES EDAAYYFCQQ HDESPYTFGE GTKVEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
-
Attributs du produit
- Anti-ROR1 Reference Antibody (zilovertamab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 146.14 kDa.
-
Pureté
- >95 %
-
Isotype
- IgG1
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
Therapeutic Agents by Target and Mechanism: ROR1 antagonist
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Stock
- 4 °C,-80 °C
-
Stockage commentaire
- +4°C,-80°C
-
-
- ROR1 (Zilovertamab Biosimilar)
-
Classe de substances
- Biosimilar
-
Poids moléculaire
- 146.14 kDa
-
UniProt
- Q01973
Antigène
-